Literature DB >> 7450398

LIver abnormalities in patients with Gaucher's disease.

S P James, F W Stromeyer, C Chang, J A Barranger.   

Abstract

Clinical and liver histopathological observations are described in 25 patients with Gaucher's disease. Although 24 patients had hepatomegaly, and the majority had abnormalities of serum transaminases, alkaline phosphatase, and BSP clearance, only 3 had evidence of portal hypertension and complications of advanced liver disease. Liver biopsies showed scattered foci of Gaucher cells in 5 patients and prominent centrilobular accumulation of Gaucher cells in 14 patients. Three patients had cirrhosis, which was associated with extensive replacement of the liver by storage cells. The severity of liver abnormalities correlated with the occurrence of other severe complications of Gaucher's disease. The wide spectrum of liver abnormalities in Gaucher's disease should be considered in evaluating trials of therapeutic enzyme replacement.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7450398

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  15 in total

1.  Glucosylceramide and lysophosphatidylcholines as potential blood biomarkers for drug-induced hepatic phospholipidosis.

Authors:  Kosuke Saito; Keiko Maekawa; Masaki Ishikawa; Yuya Senoo; Masayo Urata; Mayumi Murayama; Noriyuki Nakatsu; Hiroshi Yamada; Yoshiro Saito
Journal:  Toxicol Sci       Date:  2014-06-30       Impact factor: 4.849

Review 2.  Gaucher disease.

Authors:  Aabha Nagral
Journal:  J Clin Exp Hepatol       Date:  2014-04-21

Review 3.  Alglucerase. A pharmacoeconomic appraisal of its use in the treatment of Gaucher's disease.

Authors:  R Whittington; K L Goa
Journal:  Pharmacoeconomics       Date:  1995-01       Impact factor: 4.981

Review 4.  Imaging of Gaucher disease.

Authors:  William L Simpson; George Hermann; Manisha Balwani
Journal:  World J Radiol       Date:  2014-09-28

Review 5.  Alglucerase. A review of its therapeutic use in Gaucher's disease.

Authors:  R Whittington; K L Goa
Journal:  Drugs       Date:  1992-07       Impact factor: 9.546

6.  Selective effects of glucocerebroside (Gaucher's storage material) on macrophage cultures.

Authors:  I Gery; J S Zigler; R O Brady; J A Barranger
Journal:  J Clin Invest       Date:  1981-11       Impact factor: 14.808

7.  Massive gastrointestinal haemorrhage associated with ileal lymphoid hyperplasia in Gaucher's disease.

Authors:  D R Jones; J Hoffman; R Downie; M Haqqani
Journal:  Postgrad Med J       Date:  1991-05       Impact factor: 2.401

Review 8.  Lysosomal storage diseases.

Authors:  Carlos R Ferreira; William A Gahl
Journal:  Transl Sci Rare Dis       Date:  2017-05-25

9.  Medical treatment of biliary duct stones: effect of ursodeoxycholic acid administration.

Authors:  G Salvioli; R Salati; R Lugli; C Zanni
Journal:  Gut       Date:  1983-07       Impact factor: 23.059

10.  Loss of lysosomal membrane protein NCU-G1 in mice results in spontaneous liver fibrosis with accumulation of lipofuscin and iron in Kupffer cells.

Authors:  Xiang Y Kong; Cecilie Kasi Nesset; Markus Damme; Else-Marit Løberg; Torben Lübke; Jan Mæhlen; Kristin B Andersson; Petra I Lorenzo; Norbert Roos; G Hege Thoresen; Arild C Rustan; Eili T Kase; Winnie Eskild
Journal:  Dis Model Mech       Date:  2014-01-30       Impact factor: 5.758

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.